命を救った男は最悪の強漢魔だった。無理矢理性処理をさせられ続け輪漢沼に堕ちた救急救命医・渚恋生

命を救った男は最悪の強漢魔だった。無理矢理性処理をさせられ続け輪漢沼に堕ちた救急救命医・渚恋生

The sight of emergency doctor Nagisa Ren being tormented by a vicious rapist had me glued to the screen. This work is the second installment in a series released in November 2023 starring Reimu Kamiki, unfolding a story full of immorality set in a medical environment, much like the previous installment. Nagisa Ren plays a serious doctor who, after saving a patient, gets caught in a weakness and is successively violated within the hospital—a powerful scene that heats the chest even for non-fans.

Particularly impressive was the ending scene's depiction of entanglement in the hospital, her home ground, where being violated in her own domain throughout heightened the sense of immorality. Nagisa Ren's acting shows growth since her debut, carefully expressing emotional nuances in the drama parts and showcasing beautiful yet painful climaxes in the erotic scenes. On the other hand, many compare it to the previous Reimu Kamiki version; personally, I found Kamiki's beauty in reaching climax while being violated to be a masterpiece, but this work is no less in quality.

It's packed with intense elements typical of violation themes, such as facial ejaculation, oral cumshots, and cleanup blowjobs, living up to expectations. However, the absence of fake creampies might be due to production principles or Nagisa Ren's stance, which ironically enhances realism. In the sleep violation scenes, some point out the realistic aspect of relaxed bodies looking like mere fat lumps, but as visuals, they fully allow enjoyment of the fantasy.

Overall, the high quality of the planning shines through, and Nagisa Ren, supporting the work with her veteran-like calm acting, gives great hope for the future. This work, intertwining the doctor's agony and pleasure as she spirals into violation, is a must-watch that will undoubtedly excite fans.

Tag

Actress

Free Video

Title
命を救った男は最悪の強漢魔だった。無理矢理性処理をさせられ続け輪漢沼に堕ちた救急救命医・渚恋生
Price
500JPY〜
Distribution
Jul 29 2025
Rating
3.77 (based on 13 reviews)